MTOR and gastric cancer: After including the TNM stage, THADA expression, and mTOR expression collectively in a multifactorial survival analysis, it was observed that the advanced TNM stage (POS<0.001), low THADA expression (P=0.048), and low mTOR (P=0.008) were found to be independent poor prognostic factors for GC patients receiving postoperative 5-FU adjuvant chemotherapy (Table 2).